Royal Society of NSW News & Events

Royal Society of NSW News & Events

Southern Highlands Branch Meeting 2023-1

Dr Phillip Altman“A comprehensive review of the safety and efficacy of COVID-19 vaccines”

Dr Phillip Altman

Date: Thursday, 16 February 2022, 6.00 pm AEDT
Venue: RSL Moss vale (venue changed from the Mittagong RSL)
All are welcome

Dr Phillip Altman is a well-known Australian authority on clinical trials and regulatory affairs with more than 40 years of experience in designing, managing, and reporting clinical trials and in working with the Australian Therapeutic Goods Administration in gaining new drug approvals. He has worked in senior managerial positions for several multinational companies including Merrell-Dow, Hoechst, Roussel, and GD Searle. He established Australia’s first contract research organisations (CROs), where he served as a Senior Industry Consultant for more than half of the pharmaceutical companies present in Australia. His career has seen him involved in more than one hundred clinical trials (Phase I through IV). He has been personally responsible for the market approval of numerous new drugs since joining the pharmaceutical industry in 1974.

Dr.Altman has a comprehensive working knowledge of the international pharmaceutical standards and guidelines involved in all aspects of drug development including drug manufacture, animal and clinical safety, and efficacy testing. A graduate of Sydney University with an Honours degree in Pharmacy, Master of Science and Doctor of Philosophy degrees (focusing on drug development, pharmacology, and pharmaceutical chemistry), he co-founded and is a Life Member of the largest professional body of pharmaceutical industry scientists involved in clinical research and regulatory affairs (Association of Regulatory and Clinical Scientists to the Australian Pharmaceutical Industry Ltd. - ARCS). ARCS presently has more than 2000 members. More recently Dr. Altman was a Director and the chief clinical trial and regulatory advisor for a public company involved in the development of a live virus for the treatment of late-stage melanoma.

Dr.Altman has presented to the Cross Party Covid Inquiry held in Brisbane and has provided expert reports in relation to both the Australian and NZ Judicial Review and High Court cases in relation to the Covid vaccines.

Site by
Privacy policy |  Links to other societies
Editor Login
Disclaimer: Positions expressed on this website by authors of publications and
event presenters do not necessarily reflect those of the Society.
The Royal Society of New South Wales acknowledges the traditional custodians
of the lands on which we live and work, and we pay our respects to Elders past and present.
All rights reserved. Copyright © The Royal Society of NSW.
ABN: 76 470 896 415


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.